Qilu Antibiotics Pharmaceutical Co., Ltd.

International Qilu

Qilu Pharmaceutical people insist on "making warm innovation" and always adhere to the innovation-driven strategy. At present, the company mainly conducts a series of research and development work in the field of cephalosporin antibiotic raw materials and preparations, and new preparations. It is responsible for more than 30 science and technology plans at all levels in Shandong Province and municipality, and 1 major science and technology project in Jinan City. It has been rated as "Shandong Province Certified Enterprise" Technology Center", "Top 100 High-tech Enterprises in Shandong Province for Innovation", the first prize of Shandong Enterprise Technology Innovation, the first prize of the 2nd Shandong Science and Technology Workers Innovation Competition, and the first prize of Jinan Science and Technology Progress Award. The company has obtained 33 authorized patents, including 25 national invention patents and 8 utility models, forming a virtuous cycle of product research and development of "produce one generation, develop one generation, and reserve one generation".

Technological innovation is the first driving force for development. Qilu Pharmaceutical has always adhered to the innovation-driven development strategy, taking market demand as the core and product innovation as the guide, extensively expanding domestic and foreign research and development cooperation, focusing on the introduction and training of talents, and building a scientific and efficient R&D system.